biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by roadking08on Mar 25, 2019 11:18pm

144 Views

Post# 29534848

RE:News

I and no one else should not see today’s news release that only showed up in my junk emails and beentheres post.......the new board puts the news release of the extra 2 years of termation ajustements of these 5 million plus of warrants that would expire in a few weeks, please don’t see this as a scam. One could say....This is the venture exchange on steroids. But not me, I’m con Vince this extension of options at a buck this was done on the up & up.
i could only wish this board of directors was all in as the people on this board.

Bullboard Posts

Soma Gold poised to extend profitable track record